MOH — authorised 7 February 1979
- Marketing authorisation holder: BAXTER HLTHCARE CORP
- Status: likely_approved
MOH authorised Reglan on 7 February 1979
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 7 February 1979.
BAXTER HLTHCARE CORP holds the Israeli marketing authorisation.